- Home
- RYTM vs ACT Comparison
RYTM vs ACT Comparison
Compare RYTM & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RYTM | ACT |
|---|---|---|
| Founded | 2008 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.7B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RYTM | ACT |
|---|---|---|
| Price | $98.07 | $40.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 3 |
| Target Price | ★ $128.31 | $40.67 |
| AVG Volume (30 Days) | ★ 967.0K | 250.9K |
| Earning Date | 02-25-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | N/A | ★ 1.64 |
| EPS | N/A | ★ 4.36 |
| Revenue | $174,334,000.00 | ★ $1,224,897,000.00 |
| Revenue This Year | $47.34 | $4.60 |
| Revenue Next Year | $55.95 | $3.50 |
| P/E Ratio | ★ N/A | $9.13 |
| Revenue Growth | ★ 54.92 | 2.40 |
| 52 Week Low | $45.91 | $30.79 |
| 52 Week High | $122.20 | $40.89 |
Technical Indicators
Market Signals| Indicator | RYTM | ACT |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 62.24 |
| Support Level | $97.38 | $39.16 |
| Resistance Level | $103.20 | $40.69 |
| Average True Range (ATR) | 4.20 | 0.62 |
| MACD | -1.61 | -0.08 |
| Stochastic Oscillator | 12.15 | 84.06 |
Price Performance
Historical ComparisonAbout RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.